Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jan 14, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom has appointed William Welch to be senior VP of Diagnostics, a role in which he will be responsible for all commercial aspects of the firm’s diagnostics business. Welch formerly was senior VP and chief commercial officer at Monogram Biosciences, he was VP of sales and marketing at La Jolla Pharmaceuticals, and he worked in general management at Abbott Laboratories.

Applied DNA Sciences has named Dave Wigfield , Tom Gladtke, and Larry McIntosh to its sales and marketing team. Wigfield has been named APDN’s VP of sales for secure documents. Gladtke has been named APDN’s director of sales in for its textiles division, and McIntosh has been hired as director of sales for the company’s electronics business.

TcLand Expression has named several additions to form its scientific and medical advisory board focused on rheumatology. The board is chaired by Pierre Miossec, professor of clinical immunology and head of Immunogenetics and Inflammation Department at the Edouard Herriot Hospital of Lyon, France. Other members of the board include Paul Emery, head of the Academic Unit of Musculoskeletal Disease at Leeds General Infirmary, UK; Piet van Riel, head of the Department of Rheumatology at the University Medical Centre of Nijmegen, The Netherlands; Sara Marsal, head of the Rheumatology Research Group at the Vall d’Hebron Hospital, Spain; and Thierry Lequerré, clinician in the Department of Rheumatology at the University Hospital of Rouen, France.

Nonlinear Dynamics has expanded its sales team by hiring Leonhard Pollack and Mark Pitman. Pollack, who will be based in Germany, has over 12 years experience working at a mass spectrometry vendor. Pitman joins the company from Proteome Software and he will be based on the West Coast of the US.

Ezekiel Emanuel is leaving his position in the Office of Management and Budget, where he advised the White House as it drafted health care reform legislation, to return to the National Institutes of Health as director of the Department of Bioethics, according to the American Association for the Advancement of Science.

Kenneth Trevett, president of the Southwest Foundation for Biomedical Research, has been appointed to succeed Henry Cisneros as chair of BioMed SA’s executive committee. The company also has named Kevin Moriarty, president and CEO of Methodist Healthcare Ministries, to be vice chair, and Richard Perez, President and CEO of the San Antonio Greater Chamber, was re-elected as secretary and treasurer.

Joshua Sharfstein has stepped down from his position as principal deputy commissioner of the Food and Drug Administration to become Maryland’s secretary of health and mental hygiene. Sharfstein has served in the Obama Administration under FDA Director Margaret Hamburg since 2009 and he formerly was commissioner of health for the City of Baltimore.

Thomas Taapken will join Epigenomics as its new CFO beginning in April, when he will replace current CFO Oliver Schacht. Thomas has served as CFO of Biotie Therapies since 2008.

Genomic Health has tapped Dean Schorno to be CFO, taking over a position currently held by G. Bradley Cole. Cole will remain in his other posts at the company, where he also is COO and secretary. Schorno formerly was company senior VP of finance and he led the firm’s finance group as a director and as a senior director.

Caris Life Sciences has named Amy Jensen Cunniffe to be senior VP for government affairs. She will be responsible for Caris’ public policy and government relations efforts and will be based in Washington, DC. Cunniffe previously was GE Healthcare Leader for the Government Relations Team, and was a director at the lobbying firm Quinn, Gillespie and Associates. She also was a special assistant to the president for legislative affairs, a liaison between Congress and the White House.

Everist Genomics, formerly called Genetics Squared appointed Prasad Sunkara as its new president, effective immediately. He succeeds Bill Worzel who remains with the company in the new role as chief technology officer.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.